Tatva Chintan Pharma Chem Limited (BOM:543321)
India · Delayed Price · Currency is INR 1,114.05
+14.25 (1.30%)
At close: Apr 2, 2026
Tatva Chintan Pharma Chem Revenue
Tatva Chintan Pharma Chem had revenue of 1.31B INR in the quarter ending December 31, 2025, with 52.90% growth. This brings the company's revenue in the last twelve months to 4.80B, up 28.53% year-over-year. In the fiscal year ending March 31, 2025, Tatva Chintan Pharma Chem had annual revenue of 3.83B, down -2.74%.
Revenue (ttm)
4.80B
Revenue Growth
+28.53%
P/S Ratio
5.41
Revenue / Employee
7.06M
Employees
679
Market Cap
25.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.83B | -107.90M | -2.74% |
| Mar 31, 2024 | 3.94B | -301.08M | -7.11% |
| Mar 31, 2023 | 4.24B | -100.35M | -2.31% |
| Mar 31, 2022 | 4.34B | 1.33B | 44.38% |
| Mar 31, 2021 | 3.00B | 371.20M | 14.10% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Deepak Fertilisers And Petrochemicals Corporation | 111.62B |
| Sudarshan Chemical Industries | 83.49B |
| Thirumalai Chemicals | 18.34B |
| Camlin Fine Sciences | 17.78B |
| Vishnu Chemicals | 15.52B |
| Punjab Chemicals and Crop Protection | 10.24B |
| Transpek Industry | 6.46B |
| DMCC Speciality Chemicals | 5.29B |